Zyprexa Securities Suit Dismissed As Time-Barred
A U.S. judge has tossed a securities class action brought by shareholders of drugmaker Eli Lilly & Co. over its controversial anti-psychotic drug Zyprexa, saying the lawsuit was filed long after...To view the full article, register now.
Already a subscriber? Click here to view full article